Business Development



Business Development

Out-licensing

In order to retain greater value for the Shareholders, Zealand Pharma intends to take development programs through to clinical proof of principle before partnering, unless attractive out-licensing opportunities arise earlier.

Contact person:

Arvind M. Hundal
Senior Vice President and CBO
e-mail:   amh@zealandpharma.com

To top of page

Tip a friend

Fill in the form below to tip a friend about this page.






Subscribe

When this page is updated you will be updated by e-mail.